Shares Held (Direct Ownership) 10K
0% 3M change
n/a 12M change
Total Value Held N/A

Andrew Gengos Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 08 2025
BUY
Grant, award, or other acquisition
-
10,000 Added 50.0%
10,000 Common Stock

Also insider at

CYT
Cyteir Therapeutics, Inc. Healthcare
ATHA
Athira Pharma, Inc. Healthcare
TERN
Terns Pharmaceuticals, Inc. Healthcare
AG

Andrew Gengos

Director
Lexington, MA

Track Institutional and Insider Activities on TTRX

Follow Turn Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TTRX shares.

Notify only if

Insider Trading

Get notified when an Turn Therapeutics Inc. insider buys or sells TTRX shares.

Notify only if

News

Receive news related to Turn Therapeutics Inc.

Track Activities on TTRX